#USA #San Diego #Lennox-Gastaut #LGS Foundation #Seizure Disorders

Transforming Lives Through Research

April is a month of movement and change for the Lennox-Gastaut syndrome (LGS) community. Families, researchers, clinicians, and industry partners are uniting with a shared purpose: to advance research and improve the lives of those affected by LGS. This collaboration is embodied in the nationwide initiative, the Walks for LGS Research, taking place throughout the month.

Lennox-Gastaut syndrome is a debilitating developmental epileptic encephalopathy that impacts over one million individuals globally. Characterized by various hard-to-treat seizure types and often accompanied by developmental delays, LGS poses significant challenges for patients and families. Despite decades of research, progress has been painstakingly slow, primarily due to issues such as delayed diagnoses and a lack of effective therapies.

The Walk for LGS Research is not just an event but a catalyst for change. Proceeds from this initiative directly support the LGS Foundation’s ambitious research agenda, aimed at tackling three critical challenges in LGS: precision diagnoses, precision treatments, and whole-life care.

Precision Diagnoses

One of the key elements in enhancing outcomes for individuals with LGS is reducing the time it takes to achieve an accurate diagnosis. By funding biomarker studies and establishing a national early-diagnosis network, the LGS Foundation aims to identify LGS sooner—potentially decreasing the diagnosis timeline from years to mere months. Early identification improves not only the patient’s prognosis but also facilitates more efficient clinical trial participation.

Precision Treatments

The quest for effective treatments is a cornerstone of the LGS Foundation’s mission. The foundation is committed to catalyzing at least two disease-modifying therapies into clinical trials within the next decade. By supporting innovative scientific research, creating consortia, and focusing on patient-prioritized outcomes, the LGS Foundation positions itself as a strategic partner to biotech and pharmaceutical companies that share its vision for impactful solutions to rare diseases.

Whole-Life Care

Access and outcomes disparities are addressed through the LGS Foundation’s push to amplify recognized LGS clinics and develop a comprehensive outcomes registry. This data-driven infrastructure is designed to provide families with tangible benefits and equip researchers and the industry with valuable insights into best practices and long-term treatment effects.

Voices of the Community

Families like Mason’s, who cope with the realities of LGS, share their experiences as a testament to the urgent need for change. Tricia, Mason’s mom, expressed the challenges they face: “We threw ourselves with every ounce of energy we could find into therapies and medical treatments, but many failed to help, and some left him with side effects that dimmed his light.” The need for real answers and effective support is echoed across the community.

Get Involved

The urgency of these initiatives cannot be understated. This April, you are invited to take part in a Walk for LGS Research or to contribute in any way you can. Every effort is directed towards fostering breakthroughs that enhance the lives of those affected by LGS. Together, as a community, we can pave the way for transformative change.

About the LGS Foundation

Established as a nonprofit organization, the LGS Foundation is dedicated to playing an instrumental role in supporting families impacted by Lennox-Gastaut syndrome. The foundation educates the public about this condition, provides necessary aids to families, and catalyzes research to identify effective treatments and, ultimately, cures.